 |
| Opinion |  Top |
|
 |
|
| Editorials |
|
|
|
Transforming the root of the problem p677
doi:10.1038/nbt0696-677a
PDF
(156K)
|
|
|
|
Can ELSI's principles inform consensus? p677
doi:10.1038/nbt0696-677b
PDF
(156K)
|
|
 |
|
| Commentary |
|
|
|
Integrating maps requires integrated data p678
Jean Weissenbach
& Simone Bentolila
doi:10.1038/nbt0696-678
PDF
(155K)
|
|
|
|
Consensus, common entry, and community curation pp679 - 680
David T. Kingsbury
doi:10.1038/nbt0696-679
References | PDF
(307K)
|
|
|
|
Another salvo in the plant patent wars pp680 - 682
Russ Hoyle
doi:10.1038/nbt0696-680
PDF
(326K)
|
|
|
|
| Correspondence |
|
|
|
Monitoring transgenic plants using in vivo markers p682
C. Neal Stewart Jr.
doi:10.1038/nbt0696-682
References | PDF
(153K)
|
|
| In Brief | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Business & Regulatory News pp684 - 686
doi:10.1038/nbt0696-684
PDF
(924K)
|
|
|
|
| Research News |
|
|
|
Research News p688
doi:10.1038/nbt0696-688
PDF
(269K)
|
|
| Analysis | Top |
|
|
|
| Business and Regulatory News |
|
|
|
GlaxoWellcome and MDL become entangled in the Web p690
John Hodgson
doi:10.1038/nbt0696-690
PDF
(151K)
|
|
|
|
FBI unveils $48 million project for tracking criminal DNA p691
Stephen M. Edgington
doi:10.1038/nbt0696-691a
PDF
(324K)
|
|
|
|
NAS calls DNA forensics very robust p691
Jeffrey L. Fox
doi:10.1038/nbt0696-691b
PDF
(324K)
|
|
|
|
PPL floats IPO as companies consider transgenic switch p692
Vicki Brower
doi:10.1038/nbt0696-692a
PDF
(320K)
|
|
|
|
Genzyme leads transgenics pack p692
Vicky Brower
doi:10.1038/nbt0696-692b
PDF
(320K)
|
|
|
|
HMR builds biotechnology around core unit p694
Sylvia Davidson
doi:10.1038/nbt0696-694
PDF
(221K)
|
|
|
|
EC and US agencies fund large-scale Arabidopsis sequencing pp696 - 697
Vicki Glaser
doi:10.1038/nbt0696-696
PDF
(307K)
|
|
|
|
Insecticide preservation policy: To be or not Bt pp697 - 698
Jeffrey L. Fox
doi:10.1038/nbt0696-697
PDF
(244K)
|
|
|
|
"Nitty-gritty" FDA guidelines wanted sooner not later p698
Jeffrey L. Fox
doi:10.1038/nbt0696-698a
PDF
(135K)
|
|
|
|
2010—a pig odyssey pp698 - 700
Ian Jones
doi:10.1038/nbt0696-698b
PDF
(273K)
|
|
|
|
Heliosynthese takes on Martek infant formula market p700
John Hodgson
doi:10.1038/nbt0696-700
PDF
(157K)
|
|
|
|
| Research News |
|
|
|
Milestones in crop biotechnology—Transgenic cassava and Agrobacterium-mediated transformation of maize pp702 - 703
Indra K. Vasil
doi:10.1038/nbt0696-702
References | PDF
(265K)
|
|
|
|
Special delivery for peptide-stimulated immunity pp703 - 705
Maurice Zauderer
doi:10.1038/nbt0696-703
References | PDF
(260K)
|
|
|
|
Looking for protein family members pp705 - 706
Ronald H. Hoess
doi:10.1038/nbt0696-705
References | PDF
(293K)
|
|
|
|
TNF : Shock-free cancer remission pp706 - 708
Ferdy J. Lejeune
& Danielle Liénard
doi:10.1038/nbt0696-706
PDF
(346K)
|
|
|
|
Peptide mimetic drugs: A comment on progress and prospects p709
Lawrence M. Kauvar
doi:10.1038/nbt0696-709
References | PDF
(189K)
|
|
| Features | Top |
|
|
|
Virtually sequenced: The next genomic generation pp711 - 713
William Bains
doi:10.1038/nbt0696-711
Abstract + references | PDF
(473K)
|
|
|
|
The industrialization of plant transformation pp715 - 716
David McElroy
doi:10.1038/nbt0696-715
Abstract | PDF
(323K)
|
|
| Research Review | Top |
|
|
|
The lysis of Trypanosoma brucei brucei by human serum pp717 - 721
Stephen Tomlinson
& Jayne Raper
doi:10.1038/nbt0696-717
Abstract + references | PDF
(877K)
|
|
| Research Articles | Top |
|
|
|
Immunopotency of a viral peptide assembled on the carbohydrate moieties of self immunoglobulins pp722 - 725
Teodor-D. Brumeanu, Sofia Casares, Paul E. Harris, Philip Dehazya, Imre Wolf, Harold von Boehmer
& Constantin A. Bona
doi:10.1038/nbt0696-722
Abstract + references | PDF
(517K)
|
|
|
|
Development of friable embryogenic callus and embryogenic suspension culture systems in cassava (Manihot esculenta Crantz) pp726 - 730
Nigel J. Taylor, Michelle Edwards, Rebecca J. Kiernan, Christopher D.M. Davey, David Blakesley
& Graham G. Henshaw
doi:10.1038/nbt0696-726
Abstract + references | PDF
(597K)
|
|
|
|
Regeneration of transgenic cassava plants (Manihot esculenta Crantz) from microbombarded embryogenic suspension cultures pp731 - 735
Christian Schöpke, Nigel Taylor, Rosa Cárcamo, N'Da Koffi Konan, Philippe Marmey, Graham G. Henshaw, Roger N. Beachy
& Claude Fauquet
doi:10.1038/nbt0696-731
Abstract + references | PDF
(629K)
|
|
|
|
Genetic transformation of cassava (Manihot esculenta Crantz) pp736 - 740
Hong-Qing Li, Christof Sautter, Ingo Potrykus
& Johanna Puonti-Kaerlas
doi:10.1038/nbt0696-736
Abstract + references | PDF
(672K)
|
|
|
|
Cloning of ligand targets: Systematic isolation of SH3 domain-containing proteins pp741 - 744
Andrew B. Sparks, Noah G. Hoffman, Stephen J. McConnell, Dana M. Fowlkes
& Brian K. Kay
doi:10.1038/nbt0696-741
Abstract + references | PDF
(481K)
|
|
|
|
High efficiency transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens pp745 - 750
Yuji Ishida, Hideaki Saito, Shozo Ohta, Yukoh Hiei, Toshihiko Komari
& Takashi Kumashiro
doi:10.1038/nbt0696-745
Abstract + references | PDF
(735K)
|
|
|
|
Affinity-assisted in vivo folding of a secreted human peptide hormone in Escherichia Coli pp751 - 755
Elisabet Samuelsson, Per Jonasson, Fredrik Viklund, Björn Nilsson
& Mathias Uhlén
doi:10.1038/nbt0696-751
Abstract + references | PDF
(554K)
|
|
|
|
Increased xylanase yield in Streptomyces lividans: Dependence on number of ribosome-binding sites pp756 - 759
Nicolas Pagé, Dieter Kluepfel, François Shareck
& Rolf Morosoli
doi:10.1038/nbt0696-756
Abstract + references | PDF
(639K)
|
|
|
|
pH-sensitive, cationic liposomes: A new synthetic virus-like vector pp760 - 764
Vladimir Budker, Vladimir Gurevich, James E. Hagstrom, Fedor Bortzov
& Jon A. Wolff
doi:10.1038/nbt0696-760
Abstract + references | PDF
(553K)
|
|
|
|
An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: Export of shiga-like toxin IIeB subunit by Salmonella typhimurium aroA pp765 - 769
Barbara D. Tzschaschel, Carlos A. Guzmán, Kenneth N. Timmis
& Victor de Lorenzo
doi:10.1038/nbt0696-765
Abstract + references | PDF
(570K)
|
|
| Resources | Top |
|
|
|
| Drug Development |
|
|
|
Building your company around your clinical trials team pp771 - 772
Pat Hall
doi:10.1038/nbt0696-771
PDF
(419K)
|
|
|
|
| Patents |
|
|
|
The new section 103(b) of the patent law: An obvious solution? pp773 - 774
Charles E. Van Horn
& Stacey A. Barlow
doi:10.1038/nbt0696-773
Abstract + references | PDF
(328K)
|
|
|
|
| WWW Guide |
|
|
|
Antibodies on the Web p775
Robert S. Sikorski
& Richard Peters
doi:10.1038/nbt0696-775a
PDF
(112K)
|
|
|
|
| People |
|
|
|
People p775
doi:10.1038/nbt0696-775b
PDF
(112K)
|
|
|
|
| New Products |
|
|
|
Antibodies and Electrophoresis pp776 - 777
doi:10.1038/nbt0696-776
PDF
(359K)
|
|
|
Top |
|
|
